Inlyta 1 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DR26F9AV4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,204
Award facts
- Contract value 100% obligated
- $50,203.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $50,203.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of 180 tablets of INLYTA 1 mg, a pharmaceutical product supporting federal medical procurement needs. The award, issued on November 7, 2025, with an ultimate completion date of December 2, 2025, represents a non-competitive delivery order placed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor serving military and veteran healthcare systems.
This delivery order is a child contract stemming from AmerisourceBergen's prime indefinite delivery contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support Department of Defense healthcare programs worldwide. As a critical vendor within the DLA Medical Supply Chain, AmerisourceBergen has demonstrated its capability to fulfill federal pharmaceutical requirements through open competition, with this award exemplifying the company's role in delivering specialized medical products to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F9AV4?
SPE2DR26F9AV4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F9AV4 worth?
The government has obligated $50,204 on SPE2DR26F9AV4.
Is contract SPE2DR26F9AV4 an order under another contract?
Yes. SPE2DR26F9AV4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9AV4 competed?
The extent of competition for SPE2DR26F9AV4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award